Thought Leadership

At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.

We call it Thought Leadership.

Articles and White Papers

Service:

Scientific:

Sort by:

05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 2

In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA addresses why, when, and how to interact with the regulatory agencies to optimize the success of clinical development of a new medicinal product.
05-05-2021

NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 1

In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA presents the fundamentals of designing a successful clinical trial.
23-09-2020

Integrated product development for ATMPs

In this article, published in the September issue of MedNous, Claes and Paula discuss why an integrated product development strategy for ATMPs is essential to meet both regulatory and HTA requirements.
22-05-2020

Potential Consequences of SARS-CoV-2 to ongoing clinical programs

In this white paper, NDA’s Dr Laurie Smaldone discusses the potential impact of COVID-19 on on-going clinical trials.
17-05-2018

Regulatory strategies for value maximisation of early clinical stage assets

This white paper written by Niamh Kinsella, Biologics Expert, Paul Chamberlain, Biopharmaceuticals Expert, Josi Holz, Clinical Strategy Expert and Eva Lilienberg, Service area lead Global Development, focus on how you can strengthen your partnering nego...